Cash & equivalents decreased 26.8%
Cash & equivalents changed -26.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed -26.8% from the comparable as-filed period.
Gross margin changed +504 basis points from the comparable as-filed period.
Net income changed +330.7% from the comparable as-filed period.
Operating income changed +299.6% from the comparable as-filed period.
Operating margin changed +760 basis points from the comparable as-filed period.
Gross profit changed +19.8% from the comparable as-filed period.
Stock-based compensation changed +15.9% from the comparable as-filed period.
Inventory changed -8.6% from the comparable as-filed period. The change ranks at the 0th percentile of 4 prior comparable changes.
Research & development changed -5.9% from the comparable as-filed period.
Revenue changed +7.4% from the comparable as-filed period.
Selling, general & administrative changed +2.2% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.